Jason L. Weirather

MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma

Scott J. Rodig, Daniel Gusenleitner, Donald Jackson et al. · Science Translational Medicine · 2018 · 567 citations

Comprehensive comparison of Pacific Biosciences and Oxford Nanopore Technologies and their applications to transcriptome analysis

Jason L. Weirather, Mariateresa de Cesare, Yunhao Wang et al. · F1000Research · 2017 · 505 citations · Full text

Engineering, Biomolecular Tool, Transcriptome Complexity +29

Full‐length transcriptome sequences and splice variants obtained by a combination of sequencing platforms applied to different root tissues of <i><scp>S</scp>alvia miltiorrhiza</i> and tanshinone biosynthesis

Zhichao Xu, Reuben J. Peters, Jason L. Weirather et al. · The Plant Journal · 2015 · 354 citations · Full text

Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral Cavity Squamous Cell Carcinoma

Jonathan D. Schoenfeld, Glenn J. Hanna, Vickie Y. Jo et al. · JAMA Oncology · 2020 · 326 citations · Full text

Therapeutically Increasing MHC-I Expression Potentiates Immune Checkpoint Blockade

Shengqing Gu, Wubing Zhang, Xiaoqing Wang et al. · Cancer Discovery · 2021 · 267 citations · Full text